EP Patent

EP0336369A1 — 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones

Assigned to ER Squibb and Sons LLC · Expires 1989-10-11 · 37y expired

What this patent protects

Compounds having the formula and pharmaceutically acceptable salts thereof, exhibit antibacterial activity. R is

USPTO Abstract

Compounds having the formula and pharmaceutically acceptable salts thereof, exhibit antibacterial activity. R is

Drugs covered by this patent

Patent Metadata

Patent number
EP0336369A1
Jurisdiction
EP
Classification
—
Expires
1989-10-11
Drug substance claim
No
Drug product claim
No
Assignee
ER Squibb and Sons LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.